Henn MR, O'Brien EJ, Diao L, Feagan BG, et al. A Phase 1b safety study of SER-287, a spore-based microbiome therapeutic, for active mild to moderate ulcerative colitis. Gastroenterology 2020 Aug 4. pii: S0016-5085(20)35012.
PMID: 32763240